Special Sessions
The ISTH 2026 Congress will feature innovative Special Sessions, which will showcase unique areas of interest that are not often covered in traditional Congress sessions. See details below and visit the online program for more information:
​
The Journey from Discovery to Practice
Saturday, July 11 | 11:30-12:45 | N03-04
Speakers will share their paths from fundamental research to translational development, their discovery-to-development experiences and personal drivers behind their career choices.They will explain the challenges , issues and opportunities they encountered. Emphasize how cross-sector collaboration accelerates innovation, fosters translational research and benefits patient care.​
​
Building a Global Regulatory Collaboration Model to Bridge Evidence Gaps and Advance Women’s Health
Sunday, July 12 | 8:00-9:15 | N02
This first-of-its-kind ISTH 2026 Congress session will unite leading global regulatory agencies, medical and scientific societies, patient advocates and researchers to address how we can close post-registration evidence gaps in therapies for women with inherited and acquired bleeding and clotting disorders. Hosted by the ISTH Global Public Affairs Committee, the session will highlight gender-specific evidence needs while exploring collaborative models that can also inform broader hematologic conditions. The aim is to accelerate safe, effective and equitable patient access to innovative therapies for women worldwide. Attendees will hear presentations from multiple global regulatory agency leaders and participate in an interactive Q&A panel discussion.
​
Periods, Pregnancy, Post-menopause, and Poverty: The Lancet Haematology Commission on Global Female Health and Haematology
Monday, July 13 | 8:00-9:15 | W03-04
This session will include a brief overview of each topical section of the Lancet Haematology Commission on women’s health and hematologic diseases. Topics include: sexism in hematology, heavy menstrual bleeding, bleeding disorder diagnosis, postpartum hemorrhage, hormonal therapy associated thrombosis, pregnancy-associated thrombosis, and disparities in maternal mortality. Attendees will hear presentations from several authors of the Commission and participate in an interactive Q&A panel discussion. Hard copies of the Commission will also be available.
​
​AI in Thrombosis and Hemostasis: Inspiration for our Society
Tuesday, July 14 | 8:00-9:15 | N01
Data sciences, artificial intelligence (AI) and machine learning (ML) are gaining ground in clinical medicine and (translational) research. The opportunities seem vast because of the access to large data sets, computing power and innovative statistics. If well done, it has unparalleled possibilities. It also faces a magnitude of challenges, including ethics or big data and representation of minorities.
​